Brain Cancer
Advanced Glioblastoma
Female, 56 years
Patient Internal 1001576695
ICD-10 code
C71.8 Malignant Neoplasm of Overlapping Sites of Brain
Diagnosis (Incl. Metastases/Stage) and Year
May 2022
Advanced Glioblastoma of the Brain (WHO grade 4), IDH Wild type, EGFR Mutated, C228T Mutation in TERT Gene Promoter Sequence.
Previous Treatment
Radiation therapy, Chemotherapy (Temozolomide), Chemotherapy (Lomustine).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of Glioblastomas being around 14 months from diagnosis. Survival of patients with Inoperable Glioblastomas is approximately 7 months.
Treatment Provided
Autologous DCV (8 doses) and CIK (4 doses) over a period of 3 months.
Patient Survival/Condition and Year
Date of Review: 05/11/2023
The patient had Inoperable Glioblastoma, she survived for 14 months from the verification of Glioblastoma, meeting the median survival of Glioblastomas. She exceeded median survival for Inoperable Glioblastomas by 7 months.
